LifeMD Files DEF 14A: Executive Compensation & Pension Plans
Ticker: LFMDP · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 948320
| Field | Detail |
|---|---|
| Company | Lifemd, INC. (LFMDP) |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, corporate-governance, pension-plans
Related Tickers: LFMD
TL;DR
LifeMD's 2025 DEF 14A is out, detailing exec pay and pension plans for 2024. Check it for governance insights.
AI Summary
LifeMD, Inc. filed a DEF 14A on April 28, 2025, detailing executive compensation and corporate governance matters for the fiscal year ending December 31, 2024. The filing includes information on the company's board of directors, compensation committee, and details related to defined benefit and actuarial pension plans for both PEO and Non-PEO members. The company was formerly known as Conversion Labs, Inc. and Immudyne, Inc.
Why It Matters
This filing provides crucial transparency into how LifeMD compensates its top executives and manages its pension obligations, which can impact investor confidence and the company's financial health.
Risk Assessment
Risk Level: medium — DEF 14A filings often contain information about executive compensation and corporate governance, which can signal potential risks related to management decisions or financial health.
Key Numbers
- 2024 — Fiscal Year (Reporting period for compensation and pension plan details)
- 2023 — Fiscal Year (Prior year for comparison in pension plan details)
- 2022 — Fiscal Year (Earlier year for comparison in pension plan details)
Key Players & Entities
- LifeMD, Inc. (company) — Filer
- Conversion Labs, Inc. (company) — Former company name
- Immudyne, Inc. (company) — Former company name
- 20250428 (date) — Filing date
- 1231 (date) — Fiscal year end
FAQ
What were the key changes in executive compensation for LifeMD in fiscal year 2024?
The filing does not provide specific dollar amounts for executive compensation in 2024, but it details adjustments for defined benefit and actuarial pension plans for PEO and Non-PEO members.
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing is used to solicit proxies from shareholders for an annual meeting, typically including information on executive compensation, board of directors, and corporate governance.
When was LifeMD, Inc. previously known by other names?
LifeMD, Inc. was formerly known as Conversion Labs, Inc. (name change on 20180622) and Immudyne, Inc. (name change on 20120514 and 19950720).
What specific pension plan adjustments are detailed in the filing?
The filing mentions 'AdjustmentsForDefinedBenefitAndActuarialPensionPlansMember' for both PEO and Non-PEO members for the fiscal years 2022, 2023, and 2024.
Where is LifeMD, Inc. headquartered?
LifeMD, Inc.'s business and mail address is 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY 10001.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding LifeMD, Inc. (LFMDP).